199 related articles for article (PubMed ID: 30464675)
21. Evolving role of pharmaceutical physicians in the industry: Indian perspective.
Patil A; Rajadhyaksha V
Perspect Clin Res; 2012 Jan; 3(1):35-9. PubMed ID: 22347701
[TBL] [Abstract][Full Text] [Related]
22. To what extent do educational interventions impact medical trainees' attitudes and behaviors regarding industry-trainee and industry-physician relationships?
Carroll AE; Vreeman RC; Buddenbaum J; Inui TS
Pediatrics; 2007 Dec; 120(6):e1528-35. PubMed ID: 18055668
[TBL] [Abstract][Full Text] [Related]
23. Increasing Financial Payments From Industry to Medical Oncologists in the United States, 2014-2017.
Rahman MW; Trivedi NU; Bach PB; Mitchell AP
J Natl Compr Canc Netw; 2021 Dec; 20(13):1-9. PubMed ID: 34965511
[TBL] [Abstract][Full Text] [Related]
24. Attitudes and relationship between physicians and the pharmaceutical industry in a public general hospital in Lima, Peru.
De Ferrari A; Gentille C; Davalos L; Huayanay L; Malaga G
PLoS One; 2014; 9(6):e100114. PubMed ID: 24978481
[TBL] [Abstract][Full Text] [Related]
25. Advancing medical affair capabilities and insight generation through machine learning techniques.
Ng KKY; Zhang PC
J Pharm Policy Pract; 2023 Dec; 16(1):165. PubMed ID: 38041173
[TBL] [Abstract][Full Text] [Related]
26. The Value and Deliverables of Medical Affairs: Affiliate Perspectives and Future Expectations.
Farrington AD; Frøstrup AG; Dahl P
Pharmaceut Med; 2023 Nov; 37(6):417-424. PubMed ID: 37789114
[TBL] [Abstract][Full Text] [Related]
27. AMCP Partnership Forum: FDAMA Section 114-Improving the Exchange of Health Care Economic Data.
J Manag Care Spec Pharm; 2016 Jul; 22(7):826-31. PubMed ID: 27333323
[TBL] [Abstract][Full Text] [Related]
28. Regulating for Bias in Medical Education - Reaction to the Pharmaceutical Industry Updated EFPIA Code of Practice.
Rodzinka M; Seebohm A; Pozniak E; Mosch L; De Luca L; McArdle J; Griebenow R; Velcheva M
J Eur CME; 2019; 8(1):1685771. PubMed ID: 31807368
[TBL] [Abstract][Full Text] [Related]
29. Pharmaceutical marketing strategies' influence on physicians' prescribing pattern in Lebanon: ethics, gifts, and samples.
Khazzaka M
BMC Health Serv Res; 2019 Jan; 19(1):80. PubMed ID: 30700295
[TBL] [Abstract][Full Text] [Related]
30. Keeping modern in medicine: pharmaceutical promotion and physician education in postwar America.
Greene JA; Podolsky SH
Bull Hist Med; 2009; 83(2):331-77. PubMed ID: 19502716
[TBL] [Abstract][Full Text] [Related]
31. Are gifts from pharmaceutical companies ethically problematic? A survey of physicians.
Brett AS; Burr W; Moloo J
Arch Intern Med; 2003 Oct; 163(18):2213-8. PubMed ID: 14557219
[TBL] [Abstract][Full Text] [Related]
32. Medical doctors profile in Ethiopia: production, attrition and retention. In memory of 100-years Ethiopian modern medicine & the new Ethiopian millennium.
Berhan Y
Ethiop Med J; 2008 Jan; 46 Suppl 1():1-77. PubMed ID: 18709707
[TBL] [Abstract][Full Text] [Related]
33. The ICMJE Recommendations and pharmaceutical marketing--strengths, weaknesses and the unsolved problem of attribution in publication ethics.
Matheson A
BMC Med Ethics; 2016 Apr; 17():20. PubMed ID: 27044283
[TBL] [Abstract][Full Text] [Related]
34. Proposed guidelines for housestaff interaction with pharmaceutical companies.
Forrest DM; Ruedy J
Ann R Coll Physicians Surg Can; 1993 Oct; 26(5):291-3. PubMed ID: 15362243
[TBL] [Abstract][Full Text] [Related]
35. Policy versus practice: comparison of prescribing therapy and durable medical equipment in medical and educational settings.
Sneed RC; May WL; Stencel C
Pediatrics; 2004 Nov; 114(5):e612-25. PubMed ID: 15520092
[TBL] [Abstract][Full Text] [Related]
36. Medical affairs post-COVID 19: Are we ready to take the baton?
Rajadhyaksha VD
Perspect Clin Res; 2020; 11(3):124-127. PubMed ID: 33033702
[TBL] [Abstract][Full Text] [Related]
37. Relationships of physicians with pharmaceutical sales representatives and pharmaceutical companies: an exploratory study.
Anadaleeb SS; Tallman RF
Health Mark Q; 1996; 13(4):79-89. PubMed ID: 10159647
[TBL] [Abstract][Full Text] [Related]
38. Regulating the relationship between physicians and pharmaceutical companies: a qualitative and descriptive analysis of the impact of Israeli legislation.
Nissanholtz-Gannot R; Yankellevich A
Isr J Health Policy Res; 2017 Sep; 6(1):45. PubMed ID: 28946915
[TBL] [Abstract][Full Text] [Related]
39. Value of services provided by pharmaceutical companies: perceptions of physicians and pharmaceutical sales representatives.
Gaedeke RM; Tootelian DH; Sanders EE
Health Mark Q; 1999; 17(1):23-31. PubMed ID: 11066720
[TBL] [Abstract][Full Text] [Related]
40. Does growing up with a physician influence the ethics of medical students' relationships with the pharmaceutical industry? The cases of the US and Poland.
Makowska M
BMC Med Ethics; 2017 Aug; 18(1):49. PubMed ID: 28797266
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
